5 m bgs
6 m bgs
7 m bgs
Influent
Influent
Influent
Concentration
Concentration
Concentration
PCE
PCE
(mg/L)
(mg/L)
(mg/L)
MR
Half-Life
MR
PCE
MR
Half-Life
Month
CHCs
TOC
(%)
(h)
CHCs
TOC
(%)
Half-Life (h)
CHCs
TOC
(%)
(h)
1
150
551
96
6.3
81
495
81
10
69
249
86
1.7
3
193
454
89
23
111
468
88
27
87
248
88
3.3
6
202
407
85
20
99
527
81
21
72
205
81
6.7
9
140
367
74
23
140
504
83
12
89
154
79
15
13
114
281
79
45
149
454
86
11
60
115
69
21
19
167
91
13
143
88
10
51
64
12
266
9
h 1
t
n
o
o M
r t
e
i
r
r
a
n B
o
r
e I
v
i
t
c
a
e
le R
a
c
S
-
t
o
l
i
e P
h
f t
e o
ABLE 12.1
c
n
a
m
r
o
f
r
e
T
P
Permeable Reactive Barrier
6 m bgs
7 m bgs
Influent
Influent
Influent
Concentration
Concentration
Concentration
PCE
PCE
(mg/L)
(mg/L)
(mg/L)
MR
Half-Life
MR
PCE
MR
Half-Life
Month
CHCs
TOC
(%)
(h)
CHCs
TOC
(%)
Half-Life (h)
CHCs
TOC
(%)
(h)
1
150
551
96
6.3
81
495
81
10
69
249
86
1.7
3
193
454
89
23
111
468
88
27
87
248
88
3.3
6
202
407
85
20
99
527
81
21
72
205
81
6.7
9
140
367
74
23
140
504
83
12
89
154
79
15
13
114
281
79
45
149
454
86
11
60
115
69
21
19
167
91
13
143
88
10
51
64
12
266
9
h 1
t
n
o
o M
r t
e
i
r
r
a
n B
o
r
e I
v
i
t
c
a
e
le R
a
c
S
-
t
o
l
i
e P
h
f t
e o
ABLE 12.1
c
n
a
m
r
o
f
r
e
T
P
Permeable Reactive Barrier
